Reports and Findings
Research
The Core Story for Early Childhood Development and Learning in AustraliaInvestigators: Alana Buckley-Carr, Anna MacTiernan, Karen Forde, Kayla Newland, Samantha Veurink Partners: 303 MullenLowe, Minderoo Foundation A ‘core story’ is a powerful and memorable new story to support productive ways of thinking about issues.
Research
Bright Tomorrows Start Today (Parent App)The Bright Tomorrows app developed at The Kids Research Institute Australia aims to assist parents of children aged 0-5 years to support their child to develop the building blocks of several essential life skills.
Research
Building Out Bullying: The influence of the school environment on bullying behaviour and mental health in primary and secondary school studentsGina Trapp BHSc(Hons1A), RPHNutr, PhD Honorary Research Associate Gina.Trapp@thekids.org.au ARC DECRA Fellow & Head of Food and Nutrition Research Dr Gina Trapp is an Honorary Research Associate at The Kids Research Institute Australia. She has a
Research
Amped Up: An Energy Drink StudyGina Hayley Trapp Christian BHSc(Hons1A), RPHNutr, PhD BSc (1st Class Hons), PhD W.Aust. Honorary Research Associate Head, Child Physical Activity, Health and Development; National Heart Foundation Future Leader Fellow 08 6319 1040 Gina.Trapp@
Research
Testing the meningococcal conjugate vaccine MenACWY-TT in toddlersJennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical Research Manager Head, Vaccine Trials Group Jennifer completed her Diploma of Nursing in 1986 at Fremantle
Research
Study of an oral medication for infants hospitalized with Respiratory Syncytial Virus (RSV) infectionChristopher Jennifer Peter Blyth Kent Richmond MBBS (Hons) DCH FRACP FRCPA PhD RN MBBS MRCP(UK) FRACP Centre Head, Wesfarmers Centre of Vaccines and Infectious Diseases; Co-Head, Infectious Diseases Epidemiology, Wesfarmers Centre of Vaccines and
Research
PneumoWA: A case-control study of the role of viral and bacterial pathogens in causing pneumonia among Western Australian childrenChristopher Elke Jennifer Peter Tom Blyth Seppanen Kent Richmond Snelling MBBS (Hons) DCH FRACP FRCPA PhD BSc PhD RN MBBS MRCP(UK) FRACP BMBS DTMH GDipClinEpid PhD FRACP Centre Head, Wesfarmers Centre of Vaccines and Infectious Diseases; Co-Head,
Research
Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm InfantsJennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical Research Manager Head, Vaccine Trials Group Jennifer completed her Diploma of Nursing in 1986 at Fremantle
Research
Efficacy, Immunogenicity, and Safety Study of Clostridium difficile Toxoid Vaccine in Subjects at Risk for C. difficile InfectionJennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical Research Manager Head, Vaccine Trials Group Jennifer completed her Diploma of Nursing in 1986 at Fremantle
Research
Duration of Pertussis Immunity in Adults: A Study of Health Care WorkersJennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical Research Manager Head, Vaccine Trials Group Jennifer completed her Diploma of Nursing in 1986 at Fremantle